Audit 330633

FY End
2024-06-30
Total Expended
$48.94M
Findings
0
Programs
32
Organization: National Jewish Health (CO)
Year: 2024 Accepted: 2024-12-03

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.493 Congressional Directives $4.00M Yes 0
93.U02 National Institute of Health Contract $3.06M Yes 0
93.279 Drug Abuse and Addiction Research Programs $558,083 Yes 0
93.387 National and State Tobacco Control Program $400,000 - 0
93.257 Grants for Education, Prevention, and Early Detection of Radiogenic Cancers and Diseases $232,836 Yes 0
93.233 National Center on Sleep Disorders Research $229,016 Yes 0
93.305 National and State Tobacco Control Program $217,000 - 0
93.855 Allergy and Infectious Diseases Research $135,841 Yes 0
12.420 Military Medical Research and Development $115,640 Yes 0
93.U01 Covid-19 National Heart, Lung and Blood Institute $97,770 Yes 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $93,748 Yes 0
93.103 Food and Drug Administration Research $58,199 Yes 0
93.837 Cardiovascular Diseases Research $54,112 Yes 0
27.011 Intergovernmental Personnel Act (ipa) Mobility Program $48,813 Yes 0
93.838 Lung Diseases Research $47,250 Yes 0
47.074 Biological Sciences $45,114 Yes 0
93.396 Cancer Biology Research $33,295 Yes 0
93.113 Environmental Health $27,035 Yes 0
93.361 Nursing Research $25,094 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $20,537 Yes 0
93.113 Covid-19 Environmental Health $19,318 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $18,163 Yes 0
93.965 Coal Miners Respiratory Impairment Treatment Clinics and Services $17,263 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $16,360 Yes 0
93.859 Biomedical Research and Research Training $11,224 Yes 0
93.121 Oral Diseases and Disorders Research $10,789 Yes 0
93.262 Occupational Safety and Health Program $8,776 Yes 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $7,712 Yes 0
93.866 Aging Research $6,310 Yes 0
93.394 Cancer Detection and Diagnosis Research $6,039 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $840 Yes 0
93.350 National Center for Advancing Translational Sciences $300 Yes 0

Contacts

Name Title Type
VLQKFEEJ3NE9 Michael Dickman Auditee
3033981866 Jami Johnson Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: National Jewish Health has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance and instead to use its federally approved indirect cost rate. The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal award activity of National Jewish Health and Subsidiary (National Jewish Health) under programs of the federal government for the year ended June 30, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of National Jewish Health, it is not intended to and does not present the financial position, changes in net assets or cash flows of National Jewish Health.
Title: Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: National Jewish Health has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance and instead to use its federally approved indirect cost rate. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Title: Indirect Cost Rate Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: National Jewish Health has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance and instead to use its federally approved indirect cost rate. National Jewish Health has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance and instead to use its federally approved indirect cost rate.